Emergence of Highly Multidrug-Resistant Bacteria Isolated from Patients with Infections Admitted to Public Hospitals in Southwest Iran

Table 6

Multidrug resistance patterns of Gram-positive bacteria isolated from patients with infections.

Microorganism	Number of antibiotics	Antibiotic resistant isolates; No (%)	Multidrug resistance patterns
Enterococcus spp. (No = 117)	5	48 (41.0)	CIP, TE, GM, V, AMP
	4	26 (22.2)	CIP, TE, GM, V
	4	19 (16.2)	CIP, TE, GM, AMP
	3	6 (5.1)	CIP, TE, GM
	3	8 (6.8)	CIP, TE, V
S. aureus (No = 134)	5	3 (2.2)	CIP, GM, E, CC, SXT
	4	10 (7.5)	CIP, E, CC, TE
	3	6 (4.5)	E, SXT, CHL
	3	3 (2.2)	GM, E, CHL
	3	13 (9.7)	E, CC, TE
	3	8 (6.0)	CIP, E, CC
	3	9 (6.7)	CIP, GM, E
S. epidermidis (No = 77)	5	5 (6.5)	CIP, GM, E, CC, SXT
	4	6 (7.8)	E, CC, TE, SXT
	4	5 (6.5)	CIP, E, CC, TE
	3	2 (2.6)	GM, E, CHL
	3	8 (10.4)	E, CC, TE
	3	11 (14.3)	CIP, E, CC
	3	13 (16.9)	E, TE, SXT
S. pneumoniae (No = 49)	4	3 (6.1)	E, CC, TE, SXT
	3	5 (10.2)	E, CC, TE

CIP: Ciprofloxacin, TE: Tetracycline, GM: Gentamicin, V: Vancomycin, AMP: Ampicillin, E: Erythromycin, CC: Clindamycin, SXT: Co-Trimoxazole, and CHL: Chloramphenicol.